Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Kou-Rong Miao"'
Autor:
Jianyong Li, Lijuan Chen, Chenchen Qi, Yuan Feng, Hai-Rong Qiu, Hua Lu, Kou-Rong Miao, Si-Xuan Qian, Han Zhu, Jing Pan, Xing Shen, Han-Xin Wu
Publikováno v:
Hematology. 26:295-300
To investigate the impact of minimal residual disease (MRD) before allogeneic hematopoietic stem cell transplantation (allo-HSCT) on the outcome of acute leukemia.Data from 114 patients who were diagnosed with acute leukemia (AL) and underwent allo-H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0df98ba6265d7ad6d805ddde628bdf0
https://doi.org/10.1080/16078454.2021.1889162
https://doi.org/10.1080/16078454.2021.1889162
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Hematopoietic stem cell transplantation (HSCT) is widely used in the treatment of hematological diseases. However, complications after transplantation, such as acute and chronic graft-vs-host disease (GVHD), still seriously affect the qual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b99e73adaf83ab589277e93b057594
http://europepmc.org/articles/PMC7829719
http://europepmc.org/articles/PMC7829719
Autor:
Kou-Rong Miao, Xiao-Tong Li, Yu-Jie Wu, Wei Xu, Li Wang, Yi-Xin Zou, Yi Xia, Si-Shu Zhao, Jianyong Li, Hua-Yuan Zhu
Publikováno v:
Hematological oncologyREFERENCES. 37(4)
Ibrutinib, a first-generation Bruton's tyrosine kinase (BTK) inhibitor, could improve immunity of relapsed or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients. Whether zanubrutinib, a second-generation BTK i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f99305607ed95bfff225933e72ea347a
https://pubmed.ncbi.nlm.nih.gov/31420873
https://pubmed.ncbi.nlm.nih.gov/31420873
Autor:
Jianyong Li, Wei Wu, Kou-Rong Miao, Peng Liu, Ken H. Young, Min Hong, Hua-Yuan Zhu, Yuan Fu, Lei Fan, Wei Xu, Wenyi Shen
Publikováno v:
Oncotarget
Aberrant activation of lymphoid enhancer-binding factor-1 (LEF1) has been identified in several cancers, including chronic lymphocytic leukemia (CLL). As a key transcription factor of the Wnt/β-catenin pathway, LEF1 helps to regulate important genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f3546343c60663744b95d4fcb14db1
http://europepmc.org/articles/PMC5008311
http://europepmc.org/articles/PMC5008311
Autor:
Kou-Rong Miao, Hai-Rong Qiu, Xiaoyan Qu, Han-Xin Wu, Zhengrui Xiao, Ying Ni, Si-Xuan Qian, Guangli Yin, Jianyong Li, Lijuan Chen, Hua Lu
Publikováno v:
Tumor Biology. 37:9549-9554
Multidrug resistance 1 (MDR1) gene encodes P-glycoprotein (P-gp), which acts as an efflux pump and provides cell protection against various substances, and its single-nucleotide polymorphisms (SNPs) are associated with the development of malignant he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e663d6c3ee372d35f299138955d86e2
https://doi.org/10.1007/s13277-015-4574-9
https://doi.org/10.1007/s13277-015-4574-9
MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients
Autor:
Yu-Jie Wu, Han-Xin Wu, Zhengrui Xiao, Wei Xu, Si-Xuan Qian, Jianyong Li, Ying Ni, Hai-Rong Qiu, Kou-Rong Miao, Guangli Yin, Lei Fan, Li Wang
Publikováno v:
Tumor Biology. 37:1237-1244
MDR1 (multidrug resistance 1) encodes an adenosine triphosphate (ATP)-dependent efflux transporter that plays a fundamental role in transportation of harmful compounds outside cells to maintain optimal health. The present study was aimed to investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b1d0a5307eeb57a123a5fe75b33ad5
https://doi.org/10.1007/s13277-015-3930-0
https://doi.org/10.1007/s13277-015-3930-0
Autor:
Wei Xu, Jianyong Li, Ying Ni, Lei Fan, Han-Xin Wu, Zhengrui Xiao, Hua-Yuan Zhu, Guangli Yin, Li Wang, Si-Xuan Qian, Kou-Rong Miao
Publikováno v:
Biomedicine & Pharmacotherapy. 73:24-28
We investigated whether the MDR1 (multidrug resistance 1) gene single nucleotide polymorphism (SNP) and haplotype variants were associated with the susceptibility to diffuse large B-cell lymphoma (DLBCL). A total of 129 DLBCL patients and 208 healthy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37fcd0efc8c19519a4f5199168618645
https://doi.org/10.1016/j.biopha.2015.05.005
https://doi.org/10.1016/j.biopha.2015.05.005
Autor:
Ken H. Young, Jianyong Li, Qi Xing Gong, Jin Hua Liang, Li Wang, Lei Fan, Kou Rong Miao, Wei Xu, Zhen Wang, Ting Xun Lu, Jia Zhu Wu, Zhihong Zhang
Publikováno v:
Oncotarget
// Ting-Xun Lu 1 , Lei Fan 1 , Li Wang 1 , Jia-Zhu Wu 1 , Kou-Rong Miao 1 , Jin-Hua Liang 1 , Qi-Xing Gong 2 , Zhen Wang 2 , Ken H. Young 3 , Wei Xu 1 , Zhi-Hong Zhang 2 , Jian-Yong Li 1, 4 1 Department of Hematology, the First Affiliated Hospital of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78dec89950f038e60ebdb3f09876c1a4
http://europepmc.org/articles/PMC4621897
http://europepmc.org/articles/PMC4621897
Autor:
Jianyong Li, Lijuan Chen, Guangli Yin, Hai-Rong Qiu, Xiaoyan Qu, Kou-Rong Miao, Hua Lu, Han-Xin Wu, Zhengrui Xiao, Ying Ni, Si-Xuan Qian
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 95
Objective To illustrate the association of MDR1 (Multidrug Resistance 1) polymorphisms at loci 1236, 2677, 3435 and the prognosis of multiple myeloma (MM) in Jiangsu population. Methods A total of 129 MM patients were recruited from Jiangsu Province,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb3dd88e2544806b33f8416eb6df4583
https://pubmed.ncbi.nlm.nih.gov/28888211
https://pubmed.ncbi.nlm.nih.gov/28888211